Medico Remedies Ltd
NSE: MEDICO BSE: 540937
â‚ą18.56
-0.23 (1.22%)
Sun, 08 Nov 2026, 09:48 am
Market Cap (in Cr)156.18
PE Ratio11.15
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KMedico Remedies Analysis
dividend
- Unable to evaluate Medico Remedies's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Medico Remedies's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Medico Remedies is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Medico Remedies is profitable, therefore cash runway is not a concern.
- Medico Remedies is profitable, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 3.5x debt.
- Medico Remedies's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (73.3% vs 52.1% today).
- Interest payments on debt are well covered by earnings (EBIT is 10.9x coverage).
- Operating cash flow is negative therefore debt is not well covered.
- Medico Remedies's level of debt (52.1%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
- Haresh's remuneration is about average for companies of similar size in India.
- The tenure for the Medico Remedies management team is about average.
- The average tenure for the Medico Remedies board of directors is less than 3 years, this suggests a new board.
misc
- Medico Remedies is not covered by any analysts.
- Medico Remedies's last earnings update was 216 days ago.
past
- Medico Remedies's 1-year earnings growth exceeds its 5-year average (50.5% vs 12.5%)
- Medico Remedies's year on year earnings growth rate has been positive over the past 5 years.
- Medico Remedies's earnings growth has exceeded the IN Pharmaceuticals industry average in the past year (50.5% vs 22.7%).
- Medico Remedies used its assets less efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
- Medico Remedies's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Medico Remedies has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
value
- Medico Remedies is good value based on assets compared to the IN Pharmaceuticals industry average.
- Medico Remedies is good value based on earnings compared to the IN Pharmaceuticals industry average.
- Medico Remedies is overvalued based on earnings compared to the India market.
- BSE:540937 is down -7.8% underperforming the Pharmaceuticals industry which returned 6.8% over the past month.
- BSE:540937 is down -7.8% underperforming the market in India which returned 8% over the past month.
